MBX Biosciences (MBX) Current Leases (2023 - 2026)

MBX Biosciences has reported Current Leases for 4 years, with the latest figure at $178000.0 in Q1 2026.

• Quarterly Current Leases rose 36.92% year-over-year to $178000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $178000.0 (up 36.92% YoY) and the FY2025 annual result came in at $172000.0, up 0.58% from the prior year.
• Current Leases rose to $178000.0 in Q1 2026 per MBX's latest filing, from $172000.0 in the prior quarter.
• Over five years, Current Leases peaked at $178000.0 in Q1 2026 and troughed at $130000.0 in Q1 2025.
• A 4-year average of $157750.0 and a median of $160000.0 in 2024 frame the typical range for Current Leases.
• The sharpest annual moves came in 2025 and 2026: Current Leases fell 7.23% in 2025, then soared 36.92% in 2026.
• Over 4 years, Current Leases stood at $153000.0 in 2023, then grew by 11.76% to $171000.0 in 2024, then grew by 0.58% to $172000.0 in 2025, then increased by 3.49% to $178000.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $178000.0, $172000.0, and $154000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.